COHEN & STEERS INC (CNS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNS - US19247A1007 - Common Stock
63.95 USD
-1.14 (-1.75%)
63.95 USD
0 (0%)
Overall CNS gets a fundamental rating of 5 out of 10. We evaluated CNS against 237 industry peers in the Capital Markets industry. While CNS has a great profitability rating, there are some minor concerns on its financial health. CNS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year CNS was profitable.
- In the past year CNS has reported a negative cash flow from operations.
- In the past 5 years CNS has always been profitable.
- Of the past 5 years CNS 4 years had a positive operating cash flow.
1.2 Ratios
- CNS's Return On Assets of 20.48% is amongst the best of the industry. CNS outperforms 97.47% of its industry peers.
- With an excellent Return On Equity value of 29.83%, CNS belongs to the best of the industry, outperforming 95.36% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 24.42%, CNS belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.48% | ||
| ROE | 29.83% | ||
| ROIC | 24.42% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CNS has a Profit Margin of 29.73%. This is in the better half of the industry: CNS outperforms 73.42% of its industry peers.
- In the last couple of years the Profit Margin of CNS has grown nicely.
- The Operating Margin of CNS (33.83%) is better than 64.98% of its industry peers.
- In the last couple of years the Operating Margin of CNS has declined.
- With an excellent Gross Margin value of 88.60%, CNS belongs to the best of the industry, outperforming 92.83% of the companies in the same industry.
- In the last couple of years the Gross Margin of CNS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.83% | ||
| PM (TTM) | 29.73% | ||
| GM | 88.6% |
OM growth 3Y-4.66%
OM growth 5Y-2.01%
PM growth 3Y-3.48%
PM growth 5Y8.65%
GM growth 3Y0.67%
GM growth 5Y0.08%
2. Health
2.1 Basic Checks
- CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- CNS has an Altman-Z score of 8.99. This indicates that CNS is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 8.99, CNS belongs to the best of the industry, outperforming 93.67% of the companies in the same industry.
- There is no outstanding debt for CNS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 8.99 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CNS has a Current Ratio of 0.79. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
- CNS has a worse Current ratio (0.79) than 63.29% of its industry peers.
- CNS has a Quick Ratio of 0.79. This is a bad value and indicates that CNS is not financially healthy enough and could expect problems in meeting its short term obligations.
- CNS has a worse Quick ratio (0.79) than 62.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
- CNS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.80%.
- CNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.74% yearly.
- CNS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.04%.
- The Revenue has been growing slightly by 5.73% on average over the past years.
EPS 1Y (TTM)5.8%
EPS 3Y-5.81%
EPS 5Y3.74%
EPS Q2Q%3.85%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y-0.12%
Revenue growth 5Y5.73%
Sales Q2Q%-5.55%
3.2 Future
- The Earnings Per Share is expected to grow by 8.66% on average over the next years. This is quite good.
- CNS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.70% yearly.
EPS Next Y8.49%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
EPS Next 5Y8.66%
Revenue Next Year8.33%
Revenue Next 2Y7.78%
Revenue Next 3Y7.24%
Revenue Next 5Y6.7%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 20.63, which indicates a rather expensive current valuation of CNS.
- CNS's Price/Earnings is on the same level as the industry average.
- The average S&P500 Price/Earnings ratio is at 28.60. CNS is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 19.01, which indicates a rather expensive current valuation of CNS.
- CNS's Price/Forward Earnings ratio is in line with the industry average.
- CNS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.63 | ||
| Fwd PE | 19.01 |
4.2 Price Multiples
- 79.32% of the companies in the same industry are more expensive than CNS, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.96 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNS does not grow enough to justify the current Price/Earnings ratio.
- CNS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.43
PEG (5Y)5.52
EPS Next 2Y8.3%
EPS Next 3Y8.22%
5. Dividend
5.1 Amount
- CNS has a Yearly Dividend Yield of 3.81%.
- CNS's Dividend Yield is comparable with the industry average which is at 5.87.
- Compared to an average S&P500 Dividend Yield of 1.82, CNS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.81% |
5.2 History
- The dividend of CNS decreases each year by -7.12%.
- CNS has been paying a dividend for at least 10 years, so it has a reliable track record.
- CNS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-7.12%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 76.25% of the earnings are spent on dividend by CNS. This is not a sustainable payout ratio.
DP76.25%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
COHEN & STEERS INC / CNS FAQ
What is the ChartMill fundamental rating of COHEN & STEERS INC (CNS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CNS.
What is the valuation status for CNS stock?
ChartMill assigns a valuation rating of 3 / 10 to COHEN & STEERS INC (CNS). This can be considered as Overvalued.
Can you provide the profitability details for COHEN & STEERS INC?
COHEN & STEERS INC (CNS) has a profitability rating of 7 / 10.
Can you provide the financial health for CNS stock?
The financial health rating of COHEN & STEERS INC (CNS) is 5 / 10.
What is the expected EPS growth for COHEN & STEERS INC (CNS) stock?
The Earnings per Share (EPS) of COHEN & STEERS INC (CNS) is expected to grow by 8.49% in the next year.